Last updated on October 2016

ONYX Evaluation in the Endovascular Treatment of Cerebral Arteriovenous Malformations (cAVM)

Brief description of study

The main objective of this study is to assess the safety at 1 month after any embolization session and the efficacy at: - 12 months post last embolization in case of treatment with embolization only - 12 months after additional treatment with neurosurgery - 36 months after additional treatment with radiosurgery

Clinical Study Identifier: NCT02180958


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Maura Power

Paris, France
  Connect »